The aim of this work was to investigate whether an enzyme-linked immunosorbent assay (ELISA) was useful for early detection of maedi-visna virus (MVV) infection in sheep under field conditions. An ELISA based on p25 recombinant protein and a gp46 synthetic peptide was used. Sequentially obtained serum samples (n ϭ 1,941) were studied for 4 years. ELISA results were compared with those of the agar gel immunodiffusion (AGID) test, and results of both tests were compared with a reference result established using consensus scores for at least 2 of 3 serologic techniques (AGID, ELISA, and western blotting, which was used to resolve result discrepancies between the other 2 techniques). A total of 247 discrepancies were observed between ELISA and AGID. Of these, 131 were due to an earlier detection of 120 sera by the ELISA and 11 sera by AGID. The remaining discrepancies (116) were due to the presence of false reactions in both tests. Fewer false-negative results were found by ELISA than with AGID (6 vs. 69 sera, respectively), whereas the number of false-positive results was virtually the same for ELISA and AGID (21 vs. 20, respectively). In relation to the reference result, ELISA sensitivity and specificity were 97.8% and 98.2%, respectively, whereas values for AGID were 76.3% and 98.3%, respectively. The agreement between ELISA and the reference result was higher than that between AGID and the reference result ( value: 0.96 and 0.77, respectively). A variation in the ELISA signal (based on optical density) was observed during the study period, suggesting different antibody levels throughout the animal's life. The ELISA was useful for detecting MVV-infected sheep in field conditions and has potential for use in control and eradication programs.
Maedi-visna virus (MVV) or ovine progressive pneumonia virus is an ovine lentivirus widespread in many countries all over the world, 4, 25 and both clinical 23, 25, 26 and subclinical 14 infections cause substantial economic losses. As a consequence, accreditation for MVV-free status is becoming an important factor in sheep marketing. 25 MVV causes a persistent infection that can be demonstrated in most infected sheep by serologic assays detecting specific antibodies. 5, 10, 13, 33 To date, 1 of the most widely used diagnostic methods for detecting and controlling infection in flocks is the agar gel immunodiffusion (AGID) test. 38 The AGID test is highly specific but has low sensitivity, 11, 15 and interpretation of results depends on the experience of the person performing the test. Therefore, more sensitive and objective enzyme-linked immunosorbent assays (ELISAs) might be better alternatives for detecting seroconver-sion. Different ELISAs have been developed for detection of MVV infection. 11, 12, 21, 30, 34, 36 ELISAs based on recombinant proteins and synthetic peptides have improved MVV diagnosis 1, 15, 17, 18, 22, 24, 31, 39 and have been proposed for field diagnosis and control and eradication programs.
Previous studies have included a newly developed ELISA a based on recombinant proteins and synthetic peptides. 31 The aim of this work is to determine whether this ELISA can be used to early detect antibodies against MVV under field conditions.
Materials and methods

Serum samples
Sheep belonged to 4 Rasa Aragonesa flocks that were naturally infected with MVV and were located in the middle Ebro Valley in northeastern Spain. 20 Flocks were sampled yearly, and the seroprevalence of MVV as estimated by AGID at the beginning of the study period ranged from 7% to 52%. A total of 1,941 sera (obtained from 693 sheep) were used. Of these, 132 represented 4 annual samples from 33 adult animals, 1,584 represented 3 annual samples from 528 adult animals, 186 represented 2 annual samples from 93 adult animals, and 39 were samples obtained from 39 1-yr-old animals.
Diagnostic tests
AGID, ELISA, and individual follow-up studies. Sera were tested by AGID 38 using a commercially available diagnostic kit. b The test detects viral capsid protein (p25) and envelope glycoprotein (gp135). AGID reactions were qualitatively scored as positive or negative independently by 2 persons at 24 and 48 hr.
The ELISA was performed as previously described. 31 The 96-well ELISA plates c were coated with proteins from the EV1 strain of MVV. Two immunodominant proteins were selected, recombinant p25 (core protein) and TM1, a synthetic peptide derived from the gp46 ectodomain (envelope glycoprotein). The combination of these 2 proteins was chosen because p25 used as the sole antigen was not sufficient compared with the sensitivity of the standard AGID. 31 All sera were tested in duplicate, and 2 positive and 2 negative controls were included in each plate. Test sera (100 l) diluted 1:500 (the optimal dilution to reach maximum specificity and sensitivity) were distributed in the wells and incubated for 1 hr at 37 C. The conjugate dilution, 100 l of an affinity-purified rabbit anti-sheep IgG (HϩL chain) labeled with horseradish peroxidase (HRP), diluted 1:500 was added to wells and incubated for 60 min at 37 C. Substrate buffer (100 l) was then added. After 30 min at 22-24 C (room temperature [RT]), the reaction was stopped with 100 l of 1 N H 2 SO 4 . Absorbance of the test solution was read at dual wavelengths of 450 and 595 nm with an ELISA reader within 15 min. The cutoff value was calculated as previously indicated for this ELISA, 31 i.e., by dividing the mean of the absorbance of the positive control wells by 4 and adding to that value the mean of the absorbance of the negative control wells. The optical density (OD) ratio was defined as the result obtained after dividing the mean absorbance of duplicates by the cutoff value. Sera were considered positive when the signal of the test sample was above the cutoff value (OD ratio of Ն1 OD ratio) and negative when the signal was below the cutoff value (OD ratio of Ͻ1).
Sequential results obtained by the AGID test and the ELISA were compared for individual sheep under natural conditions. Samples showing discrepancies in the results of the AGID and the ELISA were examined with western blotting (WB).
WBlotting and polymerase chain reaction. Nitrocellulose strips were prepared for WB using sheep chondrocytes infected in vitro by MVV (EV1 strain). 2, 32 Strips were incubated overnight at RT with test sera diluted (1:100) in 10 mM Tris HCl, 150 mM NaCl, and 0.05% Tween 20 (TNT) containing 5% powdered skim milk. Strips were washed 6 times in TNT (5 min each) and incubated with anti-sheep immunoglobulin labeled with peroxidase diluted 1:1,000 d in TNT containing 5% powdered skim milk. After 2 hr at RT, strips were washed 3 times with TNT and developed by adding peroxidase substrate chromogen (0.3% 4-chloronapthol in methanol and 0.6% H 2 O 2 in TNT). A sample was considered positive by WB only when showing at least 2 specific bands against viral proteins; the most frequently observed bands were those for p25 and gp46. A positive and a negative control serum sample were always included in the WB tests. A representative example of reactions observed by WB is shown in Fig. 1 . MVV infection status in the animals used as the source of positive and negative control sera was verified by a recently developed polymerase chain reaction (PCR) technique 7 using LTR MVV primers previously described. 27 This LTR-PCR was carried out only in these control sera in peripheral blood mononuclear cells (PBMC) and complete agreement was found for AGID, ELISA, WB, and PCR results.
Choice of reference result
To consider AGID results as reference results is not optimal because the AGID test has a low sensitivity in relation to other assays. 11, 15 However, none of the known techniques are sufficiently reliable to be considered as a ''gold standard'' because they all yield false-positive and/or false-negative reactions with some samples. Thus, the reference result was established using WB, ELISA, and AGID, and MVV infection status was defined by a concordant result in at least 2 of these 3 assays, a criterion applied in previous work on MVV. 6
Determination of sensitivity, specificity, test agreement, and reliability
The relative sensitivity and specificity (ELISA vs. AGID, ELISA vs. reference result, and AGID vs. reference result) were calculated using 2 ϫ 2 contingency tables. Agreement between tests was assessed by the statistic (proportion of chance-corrected test agreement). The value can range between 0.0 and 1.0, with values Ͼ0.75 representing excellent agreement beyond chance, values between 0.40 and 0.75 indicating fair to good agreement beyond chance, and values Ͻ0.40 denoting poor agreement beyond that due to chance alone. 9 The ELISA reliability was verified by estimating intraplate and interplate coefficients of variation (CV). These CVs were calculated by dividing the SD of duplicate signals by the mean of the signals. In both cases, final intraplate and interplate CVs were calculated as the mean of all CVs obtained for all samples tested in the same experiment. Values of 7.3% and 7.7% were obtained for intraplate and interplate CVs, respectively; the lowest variability was associated with the highest absorbance values.
Results
A summary of serologic results on ELISA versus AGID comparisons is shown in Table 1 . Concordance between AGID and ELISA was obtained for 1,694 sera (87.3% of the total sample); 1,115 sera were negative and 579 were positive by both techniques. Discrepancies were observed in 247 sera (12.7% of the total sample); 37 were AGIDϩ/ELISA-and 210 were AGID-/ELISAϩ. In this situation, if the AGID results had been considered a reference standard, the value would have been 0.73 (95% confidence interval [CI] ϭ 0.70-0.76), ELISA sensitivity and specificity would have been 94.0% and 84.2%, respectively, and the overall efficacy would have been 89.1%.
Further analyses of discrepant reactions were undertaken using WB. WB results were closer to ELISA results than to AGID results, but WB strips were harder to interpret than were ELISA scores and AGID reactions, and the sensitivity of the WB technique was lower than that of the ELISA in relation to the reference result. For this reason, WB was considered useful as a backup technique, but it was disregarded as a technique to be applied in field studies. The ELISA-AGID results on sequential blood samples together with WB analysis allowed the definitive classification of discrepant AGID-ELISA serum samples into the reference result categories.
Sequential serologic studies using AGID, ELISA, and WB showed that 131 of the 247 discrepant sera were actually due to an early reaction either by ELISA or AGID ( Table 2 ). Of these, 120 (48.6%) ELISAϩ/ AGIDϪ sera, corresponding to 69 animals, evidenced an earlier detection by ELISA than by AGID (20 sera representing 4 annual samples from 5 animals, 33 sera representing 3 annual samples from 11 animals, 28 sera representing 2 annual samples from 14 animals, and 39 sera from 39 1-year-old animals). Eleven (4.4%) ELISAϪ/AGIDϩ sera, corresponding to 10 animals, evidenced an earlier detection by AGID than by ELISA (2 annual samples from 1 animal and 9 sera from 9 1-year-old animals). Results were confirmed by WB in all cases. Overall, these results demonstrate earlier detection of seropositivity to MVV in field samples by ELISA than by AGID.
The remaining 116 sera classified as false positive or false negative (Table 3 ). Of these, 41 (35.3%) sera, corresponding to 41 animals, were false positive (21 by ELISA and 20 by AGID) and 75 (64.7%) sera, corresponding to 67 animals, were false negative (6 by ELISA and 69 by AGID). Only 1 false result was observed per animal, with the exception of 8 sheep who showed 2 consecutive false-negative results by AGID (Table 3) . Sixty-nine (27.9%) false-negative and 20 (8.1%) false-positive results were detected in the AGID test, whereas only 6(2.4%) false-negative and 21 (8.5%) false-positive results were observed using ELISA. Results were confirmed by WB in all cases. Representative examples of results identifying falsepositive and false-negative sera detected by AGID or ELISA in the sequential study are shown in Fig. 2 . Therefore, with respect to ELISA performance in relation to the reference result, there were only 38 dis- crepancies: 17 false negatives and 21 false positives (Table 4 ). However, for AGID, there were 206 discrepancies with respect to the reference result: 189 false negatives and 20 false positives ( Table 5 ). The sensitivity and specificity calculated from these data for the ELISA were 97.8% and 98.2%, respectively, with an overall efficacy of 98.0%. Concerning AGID results, the sensitivity and specificity were 76.0% and 98.3%, respectively, with an overall efficacy of 87.2%. The AGID showed a fairly good agreement with the reference result ( ϭ 0.77, 95% CI ϭ 0.74-0.80), but the degree of agreement achieved by the ELISA and the reference result was much higher ( ϭ 0.96, 95% CI ϭ 0.95-0.97). The ELISA signal varied among the naturally infected animals that seroconverted throughout the study period, but variation was not always in the same direction. For example, there were animals for which an increase was observed from year 1 to year 3 (sheep 1, 2, 3, 4, 5, 7, 8, 9, 11, and 12), whereas a decrease in the second or third year was observed in other animals (sheep 6, 10, 13, 14, 15, and 16) ( Fig. 3) .
Discussion
Sequential field studies, performed over a 4-year period, demonstrate an earlier detection by the ELISA than by the AGID test for seroconversion under field conditions. This earlier detection can be explained by the higher sensitivity of ELISA compared with AGID, which is the commonly used reference test. 19, 25, 38 In this work, ELISA allowed the detection of 120 seropositive samples 1, 2, 3, or even 4 years sooner than with AGID, whereas AGID only allowed the detection of 9 samples 1 year sooner than with the ELISA and 2 samples 2 years sooner ( Table 2 ). The higher sensitivity of the ELISA was further demonstrated by the lower number of false-negative results by this test (6 vs. 69); AGID detected fewer truly seropositive sera and also failed to detect infected animals (n ϭ 8) for 2 consecutive years, favoring the spread of infection (Table 3) .
When comparing the performance of ELISA and AGID, a similarly high specificity was observed, although ELISA had a 21.5% higher sensitivity (97.8 vs. 76.3%; Tables 4, 5 ) and a 10.7% higher overall efficacy. Analogous figures on ELISA sensitivity and specificity have been obtained in previous studies involving various breeds, 31 and encouraging results have been published using other ELISAs. 11, 15, 22, 30, 34, 36 The low sensitivity of AGID (Table 5 ) may explain why, in the comparison between ELISA and AGID, the ELISA had an apparently low specificity (84.2%) and why, in relation to the reference result, the specificity of both tests (ELISA and AGID) was virtually the same (98.2% vs. 98.3%, respectively).
The low sensitivity of AGID has classically been attributed to the nature of this test, involving immunoprecipitating antibodies and partially defined viral antigens containing contaminating cellular proteins. 11, 17, 34, 36 Discrepancies in results between AGID and ELISA may thus reflect differences in antigenic determinants. These discrepancies also may reflect a real variation in the antibody response throughout the animal's life, leading to insufficient antibody titers too low to produce gel bands in the case of AGID 29 and insufficient levels of IgG immunoglobulin subclasses to give a positive reaction in the case of ELISA. In spite of its lower sensitivity, the AGID test has been very useful in MVV control programs for various European sheep breads, including Rasa Aragonesa, decreasing seroprevalence down to levels as low as 5-10%. 8 However, the use of a low-sensitivity test may jeopardize the validity of seroprevalence values, providing underestimates of these values, as observed in previous studies. 15, 28, 34 Higher progress, safety, and efficacy in eradication programs may be expected by using a more sensitive assay. The high sensitivity and specificity of the ELISA used in this study indicates that this assay is suitable for detection of seropositive Rasa Aragonesa sheep, providing evidence that the p25 protein and the peptide immunodominant domains used as ELISA antigens are sufficiently conserved between the EV1 (a British isolate used in the preparation of the ELISA 32 ) and the Spanish MVV strains. This observation also applies to sera from sheep belonging to other breeds and countries. 31 The ELISA also can be used as a diagnostic tool for semiquantitative assessment of the level of MVV-specific circulating antibodies. The rise in the ELISA signal in naturally infected sheep where seroconversion was detected during the study period ( Fig. 3) suggests that the levels of specific antibodies may vary with time, as previously suggested with other tests. 25 An increase in the ELISA signal was observed among a group of experimentally infected animals during the 12 weeks after challenge (unpublished results), further suggesting that the increase of the ELISA signal corresponds to an increase of MVV-specific antibody titers.
Although the results obtained with the ELISA in this study are encouraging, with sensitivity and specificity close to 100%, none of the tests used in this work were 100% sensitive and specific. This result is in agreement with previous findings, indicating that no single method can be considered a gold standard for MVV diagnosis, 15, 16 even though the use of WB as a reference technique has been proposed. 12, 35, 39 PCR could have been used as a reference test by itself or as a component of the reference result for this study, but PCR was not performed because PBMC samples were not available for the extensive in-field studies at the time of serum collection. Furthermore, a PCR assay with a higher sensitivity and specificity than serologic assays for viral detection in blood has not been developed. 3, 6, 37 In spite of the absence of PCR data, the reference result used in this work (WB) appeared ad-equate; the AGID sensitivity and specificity estimates obtained in this study were similar to those obtained previously. 12, 34 The early detection of the MVV infection achieved with ELISA can be useful in MVV and seroprevalence studies, increasing the efficacy of control programs currently based on AGID results. Although encouraging, these results underline the need for new tools aimed at reaching full (100%) sensitivity and specificity to reassure complete eradication of MVV infection and to facilitate animal exchanges.
